Literature DB >> 8761321

Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages.

A Matsumori1, I Okada, T Shioi, Y Furukawa, T Nakamura, K Ono, A Iwasaki, S Sasayama.   

Abstract

We investigated the effects of inotropic agents with phosphodiesterase III inhibitory properties, amrinone, pimobendan and vesnarinone, and cell permeable cyclic nucleotide analogue, 8-bromo adenosine 3'5'-cyclic monophosphate (8 Br-cAMP) on the induction of nitric oxide synthase (NOS) by lipopolysaccharide in J774A.1 macrophages in vitro. Although all three inotropic agents inhibited nitrite accumulation, the degree of inhibition was different, with pimobendan being the most potent inhibitor and amrinone the least. Vesnarinone inhibited nitrite formation biphasically. 8 Br-cAMP increased nitrite production at high concentrations, suggesting that the inhibitory effects of inotropic agents could not be explained by an increase in cAMP. Although differential inhibition of inducible NOS by inotropic agents may explain the different effects of these drugs in patients with heart failure, further study is necessary to reach this conclusion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761321     DOI: 10.1016/0024-3205(96)00378-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  The role of inflammatory mediators in the failing heart: immunomodulation of cytokines in experimental models of heart failure.

Authors:  A Matsumori; S Sasayama
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

2.  Effect of pimobendan in patients with chronic heart failure.

Authors:  N Takeda; Y Hayashi; T Arino; A Takeda; K Noma
Journal:  Exp Clin Cardiol       Date:  2001

3.  Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity.

Authors:  Si-Yu Yuan; Hai-Bo Yu; Zhen Yang; Yi-Ping Qin; Ji-Hua Ren; Sheng-Tao Cheng; Fang Ren; Betty Yuen Kwan Law; Vincent Kam Wai Wong; Jerome P L Ng; Yu-Jiao Zhou; Xin He; Ming Tan; Zhen-Zhen Zhang; Juan Chen
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

4.  Vesnarinone represses the fibrotic changes in murine lung injury induced by bleomycin.

Authors:  Minoru Inage; Hidenori Nakamura; Hiroshi Saito; Shuichi Abe; Toshihiko Hino; Noriaki Takabatake; Kyoko Terashita; Manabu Ogura; Shuichi Kato; Tetsumi Hosokawa; Makoto Sata; Hitonobu Tomoike
Journal:  Int J Biol Sci       Date:  2009-04-16       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.